These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

537 related items for PubMed ID: 8542928

  • 1. Differential effect of type I interferons on hematopoietic progenitor cells: failure of interferons to inhibit IL-3-stimulated normal and CML myeloid progenitors.
    Després D, Goldschmitt J, Aulitzky WE, Huber C, Peschel C.
    Exp Hematol; 1995 Dec; 23(14):1431-8. PubMed ID: 8542928
    [Abstract] [Full Text] [Related]

  • 2. Proliferative response of human marrow myeloid progenitor cells to in vivo treatment with granulocyte colony-stimulating factor alone and in combination with interleukin-3 after autologous bone marrow transplantation.
    Lemoli RM, Fortuna A, Fogli M, Gherlinzoni F, Rosti G, Catani L, Gozzetti A, Miggiano MC, Tura S.
    Exp Hematol; 1995 Dec; 23(14):1520-6. PubMed ID: 8542941
    [Abstract] [Full Text] [Related]

  • 3. The role of monocyte-derived hemopoietic growth factors in the regulation of myeloproliferation in juvenile chronic myelogenous leukemia.
    Emanuel PD, Bates LJ, Zhu SW, Castleberry RP, Gualtieri RJ, Zuckerman KS.
    Exp Hematol; 1991 Nov; 19(10):1017-24. PubMed ID: 1915702
    [Abstract] [Full Text] [Related]

  • 4. Modulation of the activity of a human granulocyte-macrophage colony-stimulating factor/interleukin-3 fusion protein (pIXY 321) by the macrocyclic lactone protein kinase C activator bryostatin 1.
    McCrady CW, Li F, Pettit GR, Grant S.
    Exp Hematol; 1993 Jul; 21(7):893-900. PubMed ID: 7686503
    [Abstract] [Full Text] [Related]

  • 5. Ex vivo expansion of megakaryocyte progenitors: effect of various growth factor combinations on CD34+ progenitor cells from bone marrow and G-CSF-mobilized peripheral blood.
    Gehling UM, Ryder JW, Hogan CJ, Hami L, McNiece I, Franklin W, Williams S, Helm K, King J, Shpall EJ.
    Exp Hematol; 1997 Oct; 25(11):1125-39. PubMed ID: 9328449
    [Abstract] [Full Text] [Related]

  • 6. Effects of recombinant human tumor necrosis factor on highly enriched hematopoietic progenitor cell populations from normal human bone marrow and peripheral blood and bone marrow from patients with chronic myeloid leukemia.
    Wisniewski D, Strife A, Atzpodien J, Clarkson BD.
    Cancer Res; 1987 Sep 15; 47(18):4788-94. PubMed ID: 3040231
    [Abstract] [Full Text] [Related]

  • 7. Eilatin: a novel marine alkaloid inhibits in vitro proliferation of progenitor cells in chronic myeloid leukemia patients.
    Einat M, Lishner M, Amiel A, Nagler A, Yarkorli S, Rudi A, Kashman Y, Markel D, Fabian I.
    Exp Hematol; 1995 Dec 15; 23(14):1439-44. PubMed ID: 8542929
    [Abstract] [Full Text] [Related]

  • 8. Human granulocyte-macrophage colony-stimulating factor (GM-CSF) stimulates immature marrow precursors but no CFU-GM, CFU-G, or CFU-M.
    Bot FJ, van Eijk L, Schipper P, Löwenberg B.
    Exp Hematol; 1989 Mar 15; 17(3):292-5. PubMed ID: 2645158
    [Abstract] [Full Text] [Related]

  • 9. Aberrant growth of granulocyte-macrophage progenitors in juvenile chronic myelogenous leukemia in serum-free culture.
    Sawai N, Koike K, Ito S, Okumura N, Kamijo T, Shiohara M, Amano Y, Tsuji K, Nakahata T, Oda M.
    Exp Hematol; 1996 Feb 15; 24(2):116-22. PubMed ID: 8641332
    [Abstract] [Full Text] [Related]

  • 10. Differential effects of TGF-beta 1 on normal and leukemic human hematopoietic cell proliferation.
    Murohashi I, Endho K, Nishida S, Yoshida S, Jinnai I, Bessho M, Hirashima K.
    Exp Hematol; 1995 Aug 15; 23(9):970-7. PubMed ID: 7543418
    [Abstract] [Full Text] [Related]

  • 11. In vitro sensitivity of post-bone marrow transplantation CFU-GM and BFU-E to TNF-alpha and IFN-gamma.
    Papadakis V, Ferguson KF, Heller G, Kernan NA.
    Exp Hematol; 1995 Dec 15; 23(14):1422-30. PubMed ID: 8542927
    [Abstract] [Full Text] [Related]

  • 12. Effects of in vivo treatment with PIXY321 (GM-CSF/IL-3 fusion protein) on proliferation kinetics of bone marrow and blood myeloid progenitor cells in patients with sarcoma.
    Broxmeyer HE, Benninger L, Cooper S, Hague N, Benjamin RS, Vadhan-Raj S.
    Exp Hematol; 1995 Apr 15; 23(4):335-40. PubMed ID: 7895781
    [Abstract] [Full Text] [Related]

  • 13. Effect of recombinant human stem cell factor on mafosfamide-treated bone marrow clonogenic cells.
    Carlo-Stella C, Mangoni L, Almici C, Caramatti C, Rizzoli V.
    Stem Cells; 1993 Jul 15; 11 Suppl 2():170-4. PubMed ID: 7691323
    [Abstract] [Full Text] [Related]

  • 14. Raf-1 protein is required for growth factor-induced proliferation of primitive hematopoietic progenitors stimulated with synergistic combinations of cytokines.
    Muszynski KW, Ruscetti FW, Gooya JM, Linnekin DM, Keller JR.
    Stem Cells; 1997 Jul 15; 15(1):63-72. PubMed ID: 9007224
    [Abstract] [Full Text] [Related]

  • 15. Regulation of early hematopoiesis in serum-deprived cultures of mafosfamide-treated and untreated CD34-enriched bone marrow cells.
    Ottmann OG, Stella CC, Eder M, Reutzel P, Ströcker S, Hoelzer D, Ganser A.
    Exp Hematol; 1991 Sep 15; 19(8):773-8. PubMed ID: 1714403
    [Abstract] [Full Text] [Related]

  • 16. In vitro expansion of murine hematopoietic progenitor cells by leukemia inhibitory factor, stem cell factor, and interleukin-1 beta.
    Imamura M, Zhu X, Han M, Kobayashi M, Hashino S, Tanaka J, Kobayashi S, Kasai M, Asaka M.
    Exp Hematol; 1996 Sep 15; 24(11):1280-8. PubMed ID: 8862438
    [Abstract] [Full Text] [Related]

  • 17. Interaction of transforming growth factor-beta 1 with hemopoietic growth factors in the regulation of human normal and leukemic myelopoiesis.
    Aglietta M, Stacchini A, Severino A, Sanavio F, Ferrando ML, Piacibello W.
    Exp Hematol; 1989 Mar 15; 17(3):296-9. PubMed ID: 2783914
    [Abstract] [Full Text] [Related]

  • 18. Studies of interferon as a regulator of hematopoietic cell proliferation.
    Raefsky EL, Platanias LC, Zoumbos NC, Young NS.
    J Immunol; 1985 Oct 15; 135(4):2507-12. PubMed ID: 2411798
    [Abstract] [Full Text] [Related]

  • 19. 5-Fluorouracil-resistant CD34+ cell population from peripheral blood of CML patients contains BCR-ABL-negative progenitor cells.
    Jazwiec B, Mahon FX, Pigneux A, Pigeonnier V, Reiffers J.
    Exp Hematol; 1995 Dec 15; 23(14):1509-14. PubMed ID: 8542939
    [Abstract] [Full Text] [Related]

  • 20. Selection and characterization of early hematopoietic progenitors using an anti-CD71/S06 immunotoxin.
    Benedetti G, Bondesan P, Caracciolo D, Cherasco C, Ruggieri D, Gastaldi ME, Pileri A, Gianni AM, Tarella C.
    Exp Hematol; 1994 Feb 15; 22(2):166-73. PubMed ID: 7507858
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.